Search results
Hepatic encephalopathy (HE) is a common, severe complication of advanced chronic liver disease (CLD) and has a devastating impact on the patient’s quality of life and prognosis. The neurotoxin ammonia and the presence of systemic and neurological ...
17 cze 2022 · The EASL Clinical Practice Guidelines (CPGs) on the management of hepatic encephalopathy (HE) present evidence-based answers to a set of relevant questions (where possible, formulated in PICO [patient/population, intervention, comparison and outcomes] format) on the definition, diagnosis, differential diagnosis and treatment of HE.
6 kwi 2018 · Hepatic encephalopathy (HE) is not synonym of delirium/coma in a subject with end-stage liver disease; rather it is a specific condition with its own pathophysiology. Once diagnosed, it requires a multiaxial assessment and classification.
Concurrent diabetes and CLD predict worse clinical outcomes, including hepatic decompensation, hepatocellular carcinoma (HCC), and complications following liver transplantation. Traditional glycemic markers, including fasting glucose, oral glucose tolerance test, and hemoglobin A1c, are not accurate in patients with severe CLD.
Hepatic encephalopathy (HE) is a serious neuropsychiatric complication of cirrhosis and/or porto-systemic shunting. The clinical symptoms are widely variable, extending from subtle impairment in mental state to coma.
A diagnostic flow chart is reported in Figure 1. The occurrence of precipitating events (Table3) or history of previous episodes of HE increases the pretest probability for HE, thus increasing the likeli-hood of HE when a compatible clinical pattern is recognised. Once the diagnosis of HE is confirmed, other 5 factors should
1 mar 2007 · In patients with hepatic encephalopathy who require high-carbohydrate diets, resulting in postprandial hyperglycemia, rapid-acting insulin analogs such as insulin lispro, aspart, or glulisine may be particularly useful.
